144 related articles for article (PubMed ID: 32598089)
1. A Short-Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections.
Levina A; Pires Vieira A; Wijetunga A; Kaur R; Koehn JT; Crans DC; Lay PA
Angew Chem Int Ed Engl; 2020 Sep; 59(37):15834-15838. PubMed ID: 32598089
[TBL] [Abstract][Full Text] [Related]
2. Substitution Kinetics, Albumin and Transferrin Affinities, and Hypoxia All Affect the Biological Activities of Anticancer Vanadium(V) Complexes.
Levina A; Uslan C; Murakami H; Crans DC; Lay PA
Inorg Chem; 2023 Oct; 62(43):17804-17817. PubMed ID: 37858311
[TBL] [Abstract][Full Text] [Related]
3. Vanadium(V) Pyridine-Containing Schiff Base Catecholate Complexes are Lipophilic, Redox-Active and Selectively Cytotoxic in Glioblastoma (T98G) Cells.
Kostenkova K; Levina A; Walters DA; Murakami HA; Lay PA; Crans DC
Chemistry; 2023 Dec; 29(68):e202302271. PubMed ID: 37581946
[TBL] [Abstract][Full Text] [Related]
4. Vanadium Chloro-Substituted Schiff Base Catecholate Complexes are Reducible, Lipophilic, Water Stable, and Have Anticancer Activities.
Murakami HA; Uslan C; Haase AA; Koehn JT; Vieira AP; Gaebler DJ; Hagan J; Beuning CN; Proschogo N; Levina A; Lay PA; Crans DC
Inorg Chem; 2022 Dec; 61(51):20757-20773. PubMed ID: 36519680
[TBL] [Abstract][Full Text] [Related]
5. Highly Effective and Hydrolytically Stable Vanadium(V) Amino Phenolato Antitumor Agents.
Reytman L; Braitbard O; Hochman J; Tshuva EY
Inorg Chem; 2016 Jan; 55(2):610-8. PubMed ID: 26699515
[TBL] [Abstract][Full Text] [Related]
6. Vanadium(V) tris-3,5-di-tert-butylcatecholato complex: Links between speciation and anti-proliferative activity in human pancreatic cancer cells.
Griffin E; Levina A; Lay PA
J Inorg Biochem; 2019 Dec; 201():110815. PubMed ID: 31520878
[TBL] [Abstract][Full Text] [Related]
7. Complexes of N-hydroxyethyl-N-benzimidazolylmethylethylenediaminediacetic acid with group 12 metals and vanadium-Synthesis, structure and bioactivity of the vanadium complex.
Habala L; Bartel C; Giester G; Jakupec MA; Keppler BK; Rompel A
J Inorg Biochem; 2015 Jun; 147():147-52. PubMed ID: 25920686
[TBL] [Abstract][Full Text] [Related]
8. Titanium and vanadium complexes as anticancer agents.
Kostova I
Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167
[TBL] [Abstract][Full Text] [Related]
9. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
10. Health Benefits of Vanadium and Its Potential as an Anticancer Agent.
Crans DC; Yang L; Haase A; Yang X
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394028
[TBL] [Abstract][Full Text] [Related]
11. DNA Interaction and Cytotoxic studies on Mono/Di-Oxo and Peroxo- Vanadium (V) complexes - A Review.
Kothandan S; Sheela A
Mini Rev Med Chem; 2021; 21(14):1909-1924. PubMed ID: 33687880
[TBL] [Abstract][Full Text] [Related]
12. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.
Bergeron A; Kostenkova K; Selman M; Murakami HA; Owens E; Haribabu N; Arulanandam R; Diallo JS; Crans DC
Biometals; 2019 Jun; 32(3):545-561. PubMed ID: 31209680
[TBL] [Abstract][Full Text] [Related]
14. Transport of therapeutic vanadium and ruthenium complexes by blood plasma components.
Pessoa JC; Tomaz I
Curr Med Chem; 2010; 17(31):3701-38. PubMed ID: 20846109
[TBL] [Abstract][Full Text] [Related]
15. In vitro apoptosis-induction, antiproliferative and BSA binding studies of a oxidovanadium(V) complex.
Kongot M; Dohare N; Reddy DS; Pereira N; Patel R; Subramanian M; Kumar A
J Trace Elem Med Biol; 2019 Jan; 51():176-190. PubMed ID: 30466929
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
17. In vitro antitumor activity, metal uptake and reactivity with ascorbic acid and BSA of some gold(III) complexes with N,N'-ethylenediamine bidentate ester ligands.
Pantelić N; Zmejkovski BB; Kolundžija B; Crnogorac MĐ; Vujić JM; Dojčinović B; Trifunović SR; Stanojković TP; Sabo TJ; Kaluđerović GN
J Inorg Biochem; 2017 Jul; 172():55-66. PubMed ID: 28433833
[TBL] [Abstract][Full Text] [Related]
18. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the molecular mechanism and apoptosis underlying the in-vitro and in-vivo chemotherapeutic efficacy of vanadium luteolin complex in colon cancer.
Roy S; Chakraborty T
Cell Biochem Funct; 2018 Apr; 36(3):116-128. PubMed ID: 29574863
[TBL] [Abstract][Full Text] [Related]
20. Oxovanadium(IV) complexes with Knoevenagel Schiff base condensate as impending chemotherapeutic agents: Synthesis, characterization, biological screening and anti-proliferative assay.
Paulpandiyan R; Raman N
Bioorg Chem; 2017 Aug; 73():100-108. PubMed ID: 28648922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
